The Inhibition of miR-873 Provides Therapeutic Benefit in a Lipopolysaccharide-Induced Neuroinflammatory Model of Parkinson’s Disease
Authors:
Open Access
- 16 July 2020
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-19
Abstract
Background and Purpose.Alterations in cholesterol homeostasis have been reported in cell and animal models of Parkinson’s disease (PD), although there are inconsistent data about the association between serum cholesterol levels and risk of PD. Here, we investigated the effects of miR-873 on lysosomal cholesterol homeostasis and progressive dopaminergic neuron damage in a lipopolysaccharide-(LPS) induced model of PD.Experimental Approach. To evaluate the therapeutic benefit of the miR-873 sponge, rats were injected with a LV-miR-873 sponge or the control vector 3 days before the right-unilateral injection of LPS into the substantia nigra (SN) pars compacta, or 8 and 16 days after LPS injection. Normal SH-SY5Y cells or SH-SY5Y cells overexpressingα-synuclein were used to evaluate the distribution ofα-synuclein and cholesterol in lysosomes and to assess the autophagic flux after miR-873 transfection or ABCA1 silencing. The inhibition of miR-873 significantly ameliorated the LPS-induced accumulation ofα-synuclein and loss of dopaminergic neurons in the SN at the early stage. miR-873 mediated the inhibition of ABCA1 by LPS. miR-873 transfection or ABCA1 silencing increased the lysosomal cholesterol andα-synuclein levels, and decreased the autophagic flux. The knockdown of ABCA1 or A20, which are the downstream target genes of miR-873, exacerbated the damage to LPS-induced dopaminergic neurons.Conclusion and Implications. The results suggest that the inhibition of miR-873 may play a dual protective role by improving intracellular cholesterol homeostasis and neuroinflammation in PD. The therapeutic effects of the miR-873 sponge in PD may be due to the upregulation of ABCA1 and A20.Keywords
Funding Information
- Wuhan University (TFLC 2018003, 81673503, 81173122)
- Medical Science Advancement Program (TFLC 2018003, 81673503, 81173122)
- National Natural Science Foundation of China (TFLC 2018003, 81673503, 81173122)
- National Natural Science Foundation of China (TFLC 2018003, 81673503, 81173122)
This publication has 39 references indexed in Scilit:
- ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann–Pick C2 but not Niemann–Pick C1 proteinBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in SynucleinopathiesCell, 2011
- Autophagy Regulates Cholesterol Efflux from Macrophage Foam Cells via Lysosomal Acid LipaseCell Metabolism, 2011
- Guidelines for reporting experiments involving animals: the ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme ComplexesScience, 2010
- Specific Loss of Brain ABCA1 Increases Brain Cholesterol Uptake and Influences Neuronal Structure and FunctionThe Journal of Neuroscience, 2009
- Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicityMolecular Brain, 2008
- NPC1/NPC2 function as a tag team duo to mobilize cholesterolProceedings of the National Academy of Sciences, 2008
- The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discoveryFundamental & Clinical Pharmacology, 2008
- Lipopolysaccharide Down Regulates Both Scavenger Receptor B1 and ATP Binding Cassette Transporter A1 in RAW CellsInfection and Immunity, 2002